Schlich Ltd +44(0) 1903 717001 info@schlich.co.uk
Back

Our founder, George Schlich, has a degree in Natural Sciences from Cambridge University, UK, specialising in biology of cells, chemistry, pathology, physiology, mathematics, pharmacology, and history and philosophy of science.

Highly regarded in the profession, George is credited with “leading a great team” in this year’s IAM1000. George started his career with a mixture of small molecule chemistry from US pharmaceutical companies and, closer to home, stem cell inventions from the University of Edinburgh, UK and missile guidance systems from the defence industry.

This early experience has been expanded and built on over the years. Since then, George has advised start-up companies as well as small to medium to major corporate clients in Europe and the US across the gamut of their IP interests, supporting flotations on London’s AIM market. Today, George has developed considerable experience in the protection of inventions, via patents, designs, and trade marks, in areas from stem cells to breakfast cereals, from recombinant proteins to vaccines and from inhalation pharmaceuticals to cathode arc deposition of thin films.

He specialises in patents in the chemical and biochemical fields and also advises on trade marks and designs. In relation to CRISPR/Cas9, George represents Intellia Therapeutics, Inc. George specialises in representing patent owners and opponents at inter-partes hearings before the European Patent Office (EPO), the UK Patent Office, and has extensive experience of Opposition and Appeals, meriting an entry in the UK’s “Legal 500”.

Get in touch today
Our Firm - Schlich

施利希是一家不断发展、包容性强的企业

加入我们的团队

施利希拥有一个互助共享的和睦家庭工作氛围,无论是对专业律师还是对其他专业同事。通过扁平的层级结构,我们的团队在各个层面紧密合作,因此员工和律师的保留率很高。

混合办公策略使员工能够在办公室或远程地点无缝工作。我们致力于持续进行各级员工培训。

我们强烈鼓励合理的工作/生活平衡,不希望员工的工作时间超过合同规定的时间。